Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
It’s High-Risk Class I For Vyaire’s Recall Of Bellavista Ventilators
Feb 17 2022
•
By
Shawn M. Schmitt
• Source: Shutterstock
More from Recalls
More from Policy & Regulation